This article was originally published in SRA
Swissmedic provides clarification on application requirements
You may also be interested in...
The US agency has revoked an umbrella emergency use authorization for infusion pumps and their accessories that it issued in mid-May.
Revlimid, Copaxone, Sensipar, Enbrel, Acthar Gel and Gleevec will be the subject of a US House Committee on Oversight and Reform in an upcoming drug price hearing.
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.